2011
Health Utilities for Children and Adults With Type 1 Diabetes
Lee JM, Rhee K, O'Grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES. Health Utilities for Children and Adults With Type 1 Diabetes. Medical Care 2011, 49: 924-931. PMID: 21544001, PMCID: PMC3210197, DOI: 10.1097/mlr.0b013e318216592c.Peer-Reviewed Original ResearchConceptsParent-proxy reportsType 1 diabetesHealth utilityProxy reportsEnd-stage renal diseaseEnd-stage complicationsStage renal diseaseChild Self-ReportSelf-ReportSignificant differencesRenal diseaseAdult Self-ReportHigher overall QoLOverall QoLCurrent QoLOverall qualityHigher QoLQoLFunction of ageType 1DiabetesAdultsComplicationsMethods of assessmentChildren
2000
Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls.
Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S. Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls. Diabetes 2000, 49: 2149-2153. PMID: 11118019, DOI: 10.2337/diabetes.49.12.2149.Peer-Reviewed Original ResearchConceptsSubcutaneous abdominal adipose tissueAbdominal adipose tissueBeta2-adrenergic agonistObese adolescent girlsGlycerol releaseAdipose tissueBMI 21Lean girlsObese womenObese girlsSelective beta2-adrenergic agonistAdolescent girlsSignificant differencesMobilization of fatBMI 36Lean womenAdrenergic systemLipolytic sensitivityAdolescent obesityLipolytic effectVivo stimulationBMI 38AgonistsWomenObesity